Wegovy 0.25 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FK4BT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $116,122
Award facts
- Contract value 100% obligated
- $116,122.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $116,122.26 to AmerisourceBergen Drug Corp for Wegovy (semaglutide) 0.25 mg/0.5 mL pen injections on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order was performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, and carried no set-aside designation. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across the Defense Logistics Agency and military healthcare systems. The company's SPE2DX IDC encompasses a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Wegovy, a glucagon-like peptide-1 receptor agonist used in diabetes and weight management, exemplifies the company's role in supporting military healthcare programs worldwide through flexible contract vehicles designed to meet diverse federal medical supply requirements.
Quick answers
Who was awarded contract SPE2DB25FK4BT?
SPE2DB25FK4BT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 13, 2025.
How much is contract SPE2DB25FK4BT worth?
The government has obligated $116,122 on SPE2DB25FK4BT.
Is contract SPE2DB25FK4BT an order under another contract?
Yes. SPE2DB25FK4BT is a delivery order under SPE2DB22D3019, an indefinite delivery contract.
Was contract SPE2DB25FK4BT competed?
The extent of competition for SPE2DB25FK4BT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award